glp-1 therapies success rate Chart: 1 in 8 Americans Now Use Drugs for Weight Loss Real-world persistence and adherence to
Description
Local and Accessible Care Working with a McComb, Mississippi-based specialist means you have the convenience of in-person follow-ups, along with the flexibility of virtual care options
Key Segments Analyzed Route of Administration: Parenteral administration is projected to dominate, capturing 80% of the market share by 2026
Why the Change Is Happening Now The FDA announced that shortages of GLP-1s and tirzepatide are resolved as of April 2025, impacting compounded versionscustom-made options from pharmacies
While Mounjaro has shown promising results, it is still a newer product with relatively limited market penetration compared to the more established options from Novo
Hims is not like Ozempic because Hims is a telehealth platform, not a medication
Lyons et al
